Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02049190
What this trial is testing

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate CancerAndrogen-independent Prostate Cancer+1 more
Arno Therapeutics 75
Testing effectiveness (Phase 2)Temporarily pausedNCT05361915
What this trial is testing

Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Metastatic
Sorrento Therapeutics, Inc. 100
Not applicableStudy completedNCT02489357
What this trial is testing

Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Not applicableStudy completedNCT02232230
What this trial is testing

Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T

Who this might be right for
Castrate Refractory Metastatic Prostate Cancer (mCRPC)
GenesisCare USA 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04493853
What this trial is testing

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

Who this might be right for
Hormone-Sensitive Prostate Cancer
AstraZeneca 1,012
Testing effectiveness (Phase 2)Study completedNCT03490032
What this trial is testing

68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)

Who this might be right for
Prostate Cancer Metastatic
Advanced Accelerator Applications 30
Not applicableLooking for participantsNCT04612907
What this trial is testing

Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate CancerRadiotherapy Side EffectMetastatic Cancer
Umeå University 420
Testing effectiveness (Phase 2)Looking for participantsNCT05404139
What this trial is testing

Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)

Who this might be right for
Metastatic Prostate Cancer
University Health Network, Toronto 352
Not applicableLooking for participantsNCT06468332
What this trial is testing

Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer

Who this might be right for
Prostate Cancer
Azienda Ospedaliero Universitaria Maggiore della Carita 400
Early research (Phase 1)Looking for participantsNCT05283330
What this trial is testing

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Who this might be right for
Cervical CancerBreast CancerColon Cancer+4 more
Orano Med Theranostics, SAS 48
Not applicableLooking for participantsNCT07389512
What this trial is testing

Pharmaceutical Management in Targeted Radioligand Therapy

Who this might be right for
CancerThyroid CancerMetastatic Prostate Cancer+1 more
Hospices Civils de Lyon 600
Testing effectiveness (Phase 2)Study completedNCT00068731
What this trial is testing

Lycopene in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Study completedNCT01243385
What this trial is testing

Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 44
Early research (Phase 1)Study completedNCT04087174
What this trial is testing

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 27
Testing effectiveness (Phase 2)UnknownNCT03506997
What this trial is testing

Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Institute of Cancer Research, United Kingdom 100
Not applicableWithdrawnNCT02742259
What this trial is testing

Validation of the Prostate Cancer Assay - Beta+Pivotal

Who this might be right for
Metastatic Prostate Cancer, CTC
Celsee Diagnostics
Testing effectiveness (Phase 2)Looking for participantsNCT06059118
What this trial is testing

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Early research (Phase 1)Study completedNCT02458716
What this trial is testing

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaMetastatic Prostatic AdenocarcinomaProstate Carcinoma Metastatic to the Bone
Rutgers, The State University of New Jersey 26
Testing effectiveness (Phase 2)Looking for participantsNCT07832292
What this trial is testing

JNJ-101556143 in Participants With Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 100
Post-approval studies (Phase 4)UnknownNCT03432949
What this trial is testing

Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC

Who this might be right for
Metastatic Prostate Cancer
University Health Network, Toronto 24
Next Page